Logo Logo

Publications by Ettl, J.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 4.

Journal article

Rugo, H. S.; Dieras, V.; Gelmon, K. A.; Finn, R. S.; Slamon, D. J.; Martin, M.; Neven, P.; Shparyk, Y.; Mori, A.; Lu, D. R.; Bhattacharyya, H.; Bartlett, C. Huang; Iyer, S.; Johnston, S.; Ettl, J.; Harbeck, N. (2018): Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial. In: Annals of Oncology, Vol. 29, No. 4: pp. 888-894

Dieras, V.; Harbeck, N.; Joy, A. A.; Gelmon, K. A.; Ettl, J.; Verma, S.; Lu, D.; Gauthier, E. R.; Schnell, P.; Mori, A.; Rugo, H. S.; Finn, R. S. (2017): PALOMA-2: Neutropenia (NP) patterns in patients (Pts) with estrogen receptor-positive (ER plus )/human epidermal growth factor receptor 2-negative (HER2-) first-line advanced breast cancer (ABC) receiving palbociclib plus letrozole (P plus L). In: Annals of Oncology, Vol. 28

Untch, M.; Augustin, D.; Ettl, J.; Haidinger, R.; Harbeck, N.; Lück, H.-J.; Lüftner, D.; Marée, F.; Müller, L.; Overkamp, F.; Ruckhäberle, E.; Thill, M.; Thomssen, C.; Wuerstlein, R.; Marschner, N. (2016): ABC3 Consensus Commented from the Perspective of the German Guidelines Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07.11.2015. In: Geburtshilfe und Frauenheilkunde, Vol. 76, No. 2: pp. 156-163

Rugo, H.; Dieras, V.; Gelmon, K. A.; Finn, R.; Slamon, D.; Miguel, M.; Neven, P.; Ettl, J.; Shparyk, Y.; Mori, A.; Lu, D. R.; Bhattacharyya, H.; Bartlett, C. H.; Iyer, S.; Johnston, S.; Harbeck, N. (2016): Impact of palbociclib plus letrozole on health related quality of life (HRQOL) compared with letrozole alone in treatment naive postmenopausal patients with ER+HER2-metastatic breast cancer (MBC): results from PALOMA-2. In: Annals of Oncology, Vol. 27

This list was generated on Mon Sep 16 06:43:46 2019 CEST.